Yes, hip replacement can help people with sickle cell disease when poor blood flow has badly damaged the hip bone, a problem called avascular necrosis. During surgery, the damaged joint is replaced with artificial parts. This may ease pain and improve walking when other treatments no longer help enough. Surgery needs careful planning because sickle cell disease can raise the risk of complications.
How does avascular necrosis affect the hip in sickle cell disease?
Avascular necrosis (AVN), also called osteonecrosis, occurs when part of a bone does not receive enough blood to remain healthy. In sickle cell disease, abnormally shaped red blood cells can block small blood vessels, reducing the supply of oxygen to bone tissue. The upper end of the thigh bone, called the femoral head, is particularly vulnerable because it forms the ball of the hip joint.
When bone tissue becomes damaged, the body's repair process may not be able to restore its normal strength. As AVN progresses, the femoral head can weaken, flatten, or collapse. This can damage the smooth joint surface and cause lasting pain and difficulty moving. The National Heart, Lung, and Blood Institute (NHLBI) explains that sickle cell disease can cause serious joint damage and that treatment may eventually include surgery or joint replacement.
Hip problems related to AVN can develop during adolescence or adulthood. Symptoms may include pain in the groin or hip, discomfort when walking, stiffness, and reduced movement. Pain may initially occur mainly during activity but can become more persistent as the joint deteriorates. These experiences can also have other causes, so examination and imaging are important when symptoms continue or interfere with everyday activities.
When is hip replacement recommended for avascular necrosis?
Hip replacement is generally considered when AVN has caused extensive damage to the joint, especially when the femoral head has collapsed and the hip can no longer function comfortably. Surgery may also be discussed when pain significantly limits walking, sleeping, work, or other daily activities and nonsurgical treatments have not provided enough relief.
The decision depends on the extent of bone damage, the condition of the joint surface, symptoms, age, overall health, and the person's goals for movement and daily life. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) explains that imaging helps clinicians assess osteonecrosis and that joint replacement may be needed when the bone has collapsed or other treatments are unsuccessful.
Can hip replacement be avoided if AVN is detected early?
Sometimes. When the damage is identified before the femoral head collapses, a specialist may consider treatments designed to preserve the natural joint. One option is core decompression, a procedure that involves creating small channels in the affected bone to reduce pressure and encourage healing. Depending on the area of damage, other joint-preserving procedures may also be considered.
These approaches are not suitable for every person, and they cannot reliably reverse advanced joint damage. Pain medicines, activity adjustments, walking aids, and physical therapy may help manage symptoms, but they do not necessarily stop AVN from progressing. The choice between preserving the joint and replacing it depends on the findings from examination and imaging, rather than pain alone.
How can a hip replacement help someone with sickle cell disease?
Total hip replacement, also called total hip arthroplasty, involves removing damaged bone and cartilage and replacing the ball of the femur and the surface of the hip socket with artificial components. The replacement creates a new joint surface that can move without relying on the damaged bone.
The main goals are to reduce pain, improve joint movement, and make activities such as standing, walking, and getting dressed easier. A replacement may also help someone become more active when hip damage has significantly limited mobility. However, it does not cure sickle cell disease or prevent sickling in other parts of the body, and it cannot guarantee that all pain will disappear.
The NIAMS guide to hip replacement surgery describes pain relief, improved joint function, and increased mobility as the principal goals of the operation. How much improvement a person experiences depends on the condition of the hip, other health problems, and progress during rehabilitation.
What does research say about hip replacement outcomes in sickle cell disease?
Research indicates that hip replacement can improve pain-related function and mobility in people with sickle cell disease and advanced hip osteonecrosis. However, the results are not identical for everyone, and surgery presents additional challenges in this population compared with many people undergoing replacement for other conditions.
A 2025 systematic review available through the U.S. National Library of Medicine's PubMed database found improvements in functional outcomes after total hip replacement in people with sickle cell disease. The review also reported complications, including infection, fractures, implant loosening, blood clots, and sickle cell crises. Because the included studies differed in their patients, procedures, and follow-up, their overall findings cannot predict the result for an individual person.
The evidence supports hip replacement as an important treatment option for advanced disease, but it also highlights why patient selection, preparation, surgical experience, and follow-up matter. A realistic discussion of expected benefits and possible complications is an important part of deciding whether the procedure is appropriate.
What are the risks of hip replacement with sickle cell disease?
Hip replacement is a major operation, and sickle cell disease can make the period around surgery more complicated. Stress on the body, dehydration, low oxygen levels, and other triggers may contribute to sickling complications. The surgical team must also account for the effects of chronic anemia and any other health problems that could affect recovery.
Possible complications include:
- Sickle cell pain crisis: Surgery and the recovery period can contribute to a painful episode caused by blocked blood flow.
- Acute chest syndrome: This serious sickle cell complication affects the lungs and requires urgent medical treatment.
- Infection: An infection involving the artificial joint may require prolonged treatment and sometimes another operation.
- Blood clots: Clots can develop after major surgery and may require preventive treatment.
- Fracture or implant problems: The bone around the artificial joint can fracture, or the implant may loosen or wear over time.
- Blood loss and transfusion-related complications: The team may need to manage anemia and plan carefully for any blood transfusion.
These are possible complications, not outcomes that every patient will experience. The surgical and hematology teams should explain how a person's medical history, previous sickle cell complications, and general health affect the risks of surgery.
How is surgery planned for someone with sickle cell disease?
Careful preparation is central to reducing avoidable complications. Ideally, the procedure is planned jointly by an orthopedic surgeon experienced in hip replacement, a hematologist familiar with sickle cell disease, and an anesthesiology team. Other specialists may be involved when additional health conditions need attention.
Before surgery, the team typically reviews the person's sickle cell history, previous transfusions, anemia, current medicines, other medical conditions, and imaging of the hip. They also assess the condition of the bone and plan the type of implant and surgical approach. These details help the team decide how to prepare for the operation and what monitoring may be needed afterward.
The EFORT Open Reviews guidance on total hip arthroplasty for sickle cell osteonecrosis emphasizes the special planning needs of this patient group. Measures may include a tailored transfusion plan, adequate hydration, temperature management, careful oxygen and breathing management, pain control, and steps to reduce infection and clotting risks. Blood transfusion is not a one-size-fits-all decision; the appropriate approach depends on the individual and the planned procedure.
Patients should tell their surgical team about all medicines they take and follow their instructions regarding medications, food, fluids, and preparation for anesthesia. Any fever, suspected infection, or new sickle cell complication before the operation should be reported promptly because it may affect the timing of surgery.
What is recovery like after hip replacement?
Recovery begins with monitoring after surgery, followed by a rehabilitation plan that is tailored to the patient's condition. Hospital staff watch for problems such as pain crises, breathing complications, infection, blood loss, and blood clots. The length of the hospital stay depends on the person's health, surgical progress, and support needs.
Physical therapy usually helps patients learn to walk safely, strengthen the muscles around the hip, and gradually return to daily activities. A walker, crutches, or another walking aid may be needed at first. The surgeon will decide when and how much weight can be placed on the operated leg, based on the implant, bone condition, and progress after surgery.
People with sickle cell disease may need closer medical monitoring during recovery than some other hip replacement patients. A coordinated plan for pain relief, hydration, mobility, and follow-up can help the care team identify complications early. Patients should follow their discharge instructions and attend scheduled appointments even when hip movement is improving.
Is hip replacement suitable for younger people with sickle cell disease?
AVN can begin during adolescence, so the question of hip replacement may arise in teenagers and younger adults. Age alone does not determine whether surgery is appropriate. The extent of joint damage, effect on daily life, general health, and available alternatives all contribute to the decision.
When the hip is still structurally intact, a joint-preserving procedure may be worth discussing. When the femoral head has collapsed or the joint is substantially damaged, replacement may offer greater relief than treatments that cannot restore the joint's shape. In younger patients, the team must also discuss the long-term demands placed on an artificial joint and the possibility of additional surgery in the future.
The decision should balance the benefits of improved mobility and pain relief against surgical risks and future implant care. Children and adolescents may need assessment at a center with experience in both sickle cell disease and complex hip conditions.
When should someone seek an orthopedic assessment?
Persistent hip or groin pain, increasing stiffness, a limp, or difficulty walking may warrant evaluation, particularly when symptoms interfere with daily activities or continue despite the current care plan. People already receiving care for sickle cell disease should discuss ongoing or changing hip symptoms with their hematology team and ask whether referral to an orthopedic specialist is appropriate.
Assessment may include a physical examination and imaging, such as X-rays or magnetic resonance imaging (MRI), to determine the amount of bone and joint damage. The findings help the team explain whether nonsurgical treatment, a joint-preserving procedure, or hip replacement is the most suitable option.
Sudden or rapidly worsening pain, especially with fever, inability to use the affected leg, or feeling seriously unwell, needs prompt medical assessment. These symptoms can have causes other than AVN, including conditions that require urgent treatment.
Making an informed decision about hip replacement
Hip replacement can be an effective way to reduce pain and improve movement when avascular necrosis caused by sickle cell disease has significantly damaged the hip joint. It is generally considered when the bone has collapsed or other treatments have not provided enough relief. Earlier disease may allow options that preserve the natural joint, so assessment before extensive damage develops can be useful.
Because sickle cell disease adds specific medical and surgical risks, the decision should be made with an experienced orthopedic surgeon and a hematology team. A clear plan for preparation, the operation, pain management, and rehabilitation helps patients understand the likely benefits and make an informed choice about treatment.